Related Experiment Video
Updated: Jul 21, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Multiple Sclerosis-A Demyelinating Disorder and Its Dental Considerations-A Literature Review with Own Case Report
Khalid Al Johani1, Mashael Fudah2, Mohammad Al-Zahrani3
1Department of Oral Diagnostic Sciences, Faculty of Dentistry, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Abstract:
Multiple sclerosis (MS) is a chronic, autoimmune condition that primarily affects the myelin sheath covering the neurons of the central nervous system, including those of the brain and spinal cord. Although the etiology is not completely understood, various factors, such as genetic infections and environmental background, play a role in the pathogenesis. Repeated active episodes of MS characterized with marked inflammation results in the scarring of particular nerve segments, and eventually results in functional impairment over a period of time. Based on the clinical course of the disease, four clinical types of MS have been identified, with the relapsing-remitting type being the commonest. MS is known to occur more commonly in females in the age group of 20-40 years. Dysarthria, fatigue, muscle spasm, and numbness are the common presenting symptoms of MS. Diagnosis is generally achieved with MRI brain scans, showing demyelination plaques and lumbar puncture. Treatment of MS's acute phase includes high doses of corticosteroids; whereas preventive treatment of MS includes the prescription of immunosuppressive therapy, including biologics. A large group of MS patients present with oral manifestations, including dysphagia, dysarthria, temporomandibular joint (TMJ) disturbances, facial palsy, and chronic periodontal diseases. Other typical oral manifestations seen in MS patients include trigeminal neuralgia, paresthesia, or orofacial pain. Dental treatment and following drug prescription needs to be tailored to each patient, as there is a possibility of drug interactions. This paper presents a comprehensive, updated review of MS, with emphasis on oral manifestations and dental considerations. Additionally, it presents a case of a 40-year-old female diagnosed with MS that was presented to a dental hospital. The report discusses the oral manifestations and dental management.
Insights
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system. This review details MS oral manifestations and dental management considerations for patients.
Area of Science:
- Neurology
- Immunology
- Dental Medicine
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease targeting the central nervous system's myelin sheath.
- Its exact cause is unknown, but genetic, infectious, and environmental factors contribute to its pathogenesis.
- MS involves inflammatory episodes leading to nerve scarring and functional impairment, with relapsing-remitting MS being most common.
Purpose of the Study:
- To provide a comprehensive review of multiple sclerosis (MS).
- To emphasize the oral manifestations associated with MS.
- To discuss essential dental considerations for MS patients.
Main Methods:
- Literature review of multiple sclerosis (MS).
- Analysis of common oral manifestations in MS patients.
- Case report of a 40-year-old female MS patient presenting to a dental hospital.
Main Results:
- MS commonly affects females aged 20-40, presenting with symptoms like dysarthria, fatigue, and numbness.
- Diagnosis involves MRI and lumbar puncture; treatment includes corticosteroids and immunosuppressants.
- Oral manifestations such as dysphagia, dysarthria, TMJ issues, facial palsy, periodontal disease, trigeminal neuralgia, and orofacial pain are prevalent in MS patients.
Conclusions:
- MS requires tailored dental treatment plans due to potential drug interactions.
- Understanding oral manifestations is crucial for comprehensive MS patient care.
- This review highlights the importance of integrating dental management into the overall care of individuals with multiple sclerosis.

